Open enrollment starts January 2026
Your members are unique. Their care should be, too.
Lightpath draws from Verily’s deep clinical expertise, as well experience in health tech, healthcare regulation, and data science to offer programs delivered from a comprehensive clinical care team, inclusive of medical provider coverage in all 50 states, and AI-enabled support.
Lightpath will provide your plan members more accessible, timely, tailored and engaging care pathways to support better chronic care program adherence, outcomes and costs.
A flexible, multi-tiered solution*
Help more members meet and maintain health goals
Lightpath provides comprehensive and flexible care programs, offering multiple tiers of resourcing based on clinical need. With Lightpath’s intelligent program design, resourcing is purposefully matched, enabling the right care at the right time and maximizing ROI (see the figure and details below), starting with programs to help manage type 1 and type 2 diabetes, prediabetes, weight loss, obesity, hypertension, and hyperlipidemia.
Metabolic Intensive focuses on members with uncontrolled type 1 and 2 diabetes or hypertension (A1C of 8.0% or greater, or blood pressure >130/80 mmHg), inclusive of comorbidities. Members will have access to health coaches, physicians, pharmacists and registered dietitians, as clinically indicated, and paired with AI-enabled support. Plus, medical provider coverage is in all 50 states.
Evidence-based care
Proven chronic care outcomes
Lightpath is an evolution of Verily Onduo virtual care management for chronic conditions, building off its best practices and learnings, and to be reflective of its successes, such as demonstrated outcomes. A peer-reviewed, 4-month study of Verily Onduo with intermittent CGM use in adults with type 2 diabetes showed meaningful glycemic improvements. Improvements in other metabolic health parameters, including weight‡ and blood pressure, were also observed.1
Image: 2.4% A1C decrease in high-risk participants (avg.), 2.4 hours per day increase in time in target blood glucose range (avg.), 4.4 mmHg reduction in systolic blood pressure (total, avg.), 16.6 mg/dL decrease in total cholesterol (avg.) and 9 pound weight loss (avg.). Note: Weight loss results are not guaranteed. Individual weight loss outcomes, amount and time duration will vary.
A smarter, personalized approach*
The right care, at the right time
Members receive tailored nutrition content, nudges and interventions, as well as holistic medication services, including support for GLP-1s and other anti-obesity medications.†
As an evidence-based, learning health system model, Lightpath will continually improve care quality and patient outcomes. With GLP-1 use, the learning platform will inform the right GLP-1 utilization and clinical care for promoting better health and lower costs. This combined with an ongoing, comprehensive care approach and expert clinical team means members can overcome barriers to care for sustainable progress.
Lightpath will dynamically navigate members through our fit-for-member solution as they achieve health outcomes, while optimizing costs and member experience.
1. Majithia AR, Kusiak CM, Improved Glycemic Outcomes in Adults With Type 2 Diabetes Participating in a Continuous GlucoseMonitor Driven Virtual Diabetes Clinic: A Prospective J Med Internet Res. 2020;22(8):e21778. doi:10.2196/21778 n=55; 60 days intermittent CGM wear, n=43
*The information contained on this page is intended to outline Verily’s general product direction and is not a commitment or legal obligation to deliver any functionality. Product capabilities, timeframes and features are subject to change and should not be viewed as commitments.
†Statements related to Rx treatments are for members receiving telemedicine services with licensed health care providers through Onduo P.C
‡Weight loss results are not guaranteed. Individual weight loss outcomes, amount and time duration will vary.
Persons aren’t actual Verily care program or Verily Me members or providers.
Product and solution images are also for illustrative purposes only.
Verily Me is not a medical device and has not been evaluated by the FDA.
Verily Life Sciences LLC (“Verily”) offers virtual care management programs for eligible individuals, as further described in these materials and at verily.com. Verily collaborates with Onduo Management Services LLC (“OMS”), Onduo LLC, and a network of affiliated Professional Entities to offer the services. These services are meant to be used in conjunction with regular in-person clinical services and not intended to replace routine primary care.
Verily makes available virtual care management programs for eligible individuals, as further described in this document and at Verily.com, and works with the following organizations who coordinate to deliver their respective services through the technology solution developed by Verily Life Sciences LLC: Onduo Professionals PC and other affiliated professional entities delivering clinical care; and Onduo Management Services LLC (“OMS”) and Onduo LLC (a licensed durable medical equipment company), wholly owned subsidiaries of Verily Life Sciences LLC. How it works: Verily works with a network of care providers. The Lightpath care team reviews health information from the member’s health record and direct member input to provide tailored dietary, lifestyle, and medication recommendations utilizing clinical expertise, along with professional guidelines, where applicable.